首页 > 最新文献

Nephrologie & Therapeutique最新文献

英文 中文
Pathophysiology of ANCA vasculitis ANCA血管炎的病理生理学
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-06-13 DOI: 10.1684/ndt.2023.29
Jean-François Augusto, Benoit Brilland

ANCA vasculitides (AAV) are autoimmune diseases responsible for damage to small-size vessels. Three entities are distinguished from clinical, histological and biological criteria: micropolyangiitis (MPA), granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA). The neutrophil-ANCA couple is central to the pathophysiology of AAV. The mechanisms that lead to the breakdown of tolerance to myeloperoxidase or proteinase-3 remain hypothetical, however, probably multifactorial, occurring on a predisposing genetic background. The understanding of the injury mechanisms involved in AAV has made great progress thanks to the study of a murine model of immunization against myeloperoxidase. This work has made it possible to show the central role of the PNN in vivo, which are activated under sterile conditions, under the effect of the ANCAs which recognize the self-antigen expressed on their surface. Understanding the role of the alternative complement pathway and in particular that of C5a, a powerful anaphylatoxin, was a major advance. C5a acts as an amplifying factor for PNN activation and blocking its receptor (C5aR) prevents the occurrence of vasculitis lesions in the mouse model. These discoveries led to therapeutic trials in humans highlighting the interest of blocking C5aR and validating this therapeutic strategy. It should be emphasized that the AAV study model is, above all, an anti-MPO model and that the mechanisms involved in anti-PR3 ANCA or ANCA negative vasculitis remain very hypothetical. Finally, the mechanisms that account for the heterogeneity relating to the presentation or severity of AAV remain poorly understood.

ANCA血管粥样硬化(AAV)是一种自身免疫性疾病,可导致小血管损伤。从临床、组织学和生物学标准来区分三种实体:微多血管炎(MPA)、多血管性肉芽肿病(GPA)和多血管性嗜酸性肉芽肿病(EGPA)。中性粒细胞- anca对AAV的病理生理至关重要。然而,导致骨髓过氧化物酶或蛋白酶-3耐受性崩溃的机制仍然是假设的,可能是多因素的,发生在易感的遗传背景上。由于对小鼠脊髓过氧化物酶免疫模型的研究,对AAV损伤机制的理解取得了很大进展。这项工作已经有可能显示PNN在体内的核心作用,在无菌条件下,在识别其表面表达的自身抗原的anca的作用下被激活。了解替代补体途径的作用,特别是C5a(一种强效过敏毒素)的作用是一项重大进展。C5a作为PNN激活的放大因子,阻断其受体(C5aR)可防止小鼠模型血管炎病变的发生。这些发现导致了人类的治疗试验,强调了阻断C5aR的兴趣,并验证了这种治疗策略。应该强调的是,AAV研究模型首先是一个抗mpo模型,抗pr3 ANCA或ANCA阴性血管炎的机制仍然是非常假设的。最后,与AAV的表现或严重程度相关的异质性机制仍然知之甚少。
{"title":"Pathophysiology of ANCA vasculitis","authors":"Jean-François Augusto,&nbsp;Benoit Brilland","doi":"10.1684/ndt.2023.29","DOIUrl":"https://doi.org/10.1684/ndt.2023.29","url":null,"abstract":"<p><p>ANCA vasculitides (AAV) are autoimmune diseases responsible for damage to small-size vessels. Three entities are distinguished from clinical, histological and biological criteria: micropolyangiitis (MPA), granulomatosis with polyangiitis (GPA) and eosinophilic granulomatosis with polyangiitis (EGPA). The neutrophil-ANCA couple is central to the pathophysiology of AAV. The mechanisms that lead to the breakdown of tolerance to myeloperoxidase or proteinase-3 remain hypothetical, however, probably multifactorial, occurring on a predisposing genetic background. The understanding of the injury mechanisms involved in AAV has made great progress thanks to the study of a murine model of immunization against myeloperoxidase. This work has made it possible to show the central role of the PNN in vivo, which are activated under sterile conditions, under the effect of the ANCAs which recognize the self-antigen expressed on their surface. Understanding the role of the alternative complement pathway and in particular that of C5a, a powerful anaphylatoxin, was a major advance. C5a acts as an amplifying factor for PNN activation and blocking its receptor (C5aR) prevents the occurrence of vasculitis lesions in the mouse model. These discoveries led to therapeutic trials in humans highlighting the interest of blocking C5aR and validating this therapeutic strategy. It should be emphasized that the AAV study model is, above all, an anti-MPO model and that the mechanisms involved in anti-PR3 ANCA or ANCA negative vasculitis remain very hypothetical. Finally, the mechanisms that account for the heterogeneity relating to the presentation or severity of AAV remain poorly understood.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 S1","pages":"1-9"},"PeriodicalIF":0.7,"publicationDate":"2023-06-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10084381","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Comprehensive conservative care for the management of advanced chronic kidney disease: overview and perspectives 晚期慢性肾脏疾病的综合保守治疗:综述与展望
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-06-12 DOI: 10.1684/ndt.2023.28
Aghiles Hamroun, François Glowacki

Comprehensive “conservative care” is defined as any active therapeutic procedure for the management of stage 5 chronic kidney disease without recourse to dialysis. This therapeutic option is discussed in elderly, frail patients whose anticipated life expectancy is reduced with dialysis. The decision for conservative management primarily relies on an informed choice by the patient and his caregivers. This holistic approach, focused on quality of life, requires a multidisciplinary approach. The goals are to slow the progression of kidney disease, prevent complications, anticipate the risks of decompensation, provide support for the patient and his caregivers to maintain the best possible quality of life at home. This article describes the principles of conservative management, highlights various barriers to this care pathway, and proposes potential solutions.

全面的“保守治疗”被定义为任何不依赖透析的5期慢性肾脏疾病管理的积极治疗程序。这种治疗选择讨论了老年人,体弱患者的预期寿命因透析而降低。保守治疗的决定主要依赖于患者及其护理人员的知情选择。这种注重生活质量的整体方法需要多学科方法。目标是减缓肾脏疾病的进展,预防并发症,预测失代偿的风险,为患者及其护理人员提供支持,以维持尽可能高的家庭生活质量。本文描述了保守管理的原则,强调了这种护理途径的各种障碍,并提出了潜在的解决方案。
{"title":"Comprehensive conservative care for the management of advanced chronic kidney disease: overview and perspectives","authors":"Aghiles Hamroun,&nbsp;François Glowacki","doi":"10.1684/ndt.2023.28","DOIUrl":"https://doi.org/10.1684/ndt.2023.28","url":null,"abstract":"<p><p>Comprehensive “conservative care” is defined as any active therapeutic procedure for the management of stage 5 chronic kidney disease without recourse to dialysis. This therapeutic option is discussed in elderly, frail patients whose anticipated life expectancy is reduced with dialysis. The decision for conservative management primarily relies on an informed choice by the patient and his caregivers. This holistic approach, focused on quality of life, requires a multidisciplinary approach. The goals are to slow the progression of kidney disease, prevent complications, anticipate the risks of decompensation, provide support for the patient and his caregivers to maintain the best possible quality of life at home. This article describes the principles of conservative management, highlights various barriers to this care pathway, and proposes potential solutions.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 S1","pages":"1-9"},"PeriodicalIF":0.7,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10065222","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Contribution of immunology: immune response to vaccination and limits 免疫学的贡献:免疫应答和限制
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-06-12 DOI: 10.1684/ndt.2023.27
Étienne Brochot

Advances over the past 50 years in the field of vaccination and the exploration of the immune response offer positive prospects for the prevention of infectious diseases. However, there is still a long way to go to improve the efficacy and safety of vaccination for transplant recipients or immunocompromised patients in the broad sense. In these populations, the benefit/risk balance of vaccination is even more pronounced in favor than that of the general population. Thus, consistently generating data in these populations is of great importance but can be disrupted by various human, technical and financial factors. In this text, we will attempt to describe some of these limitations for the immune response to vaccination and its exploration, especially in transplant recipients.

在过去的50年里,疫苗接种领域的进展和免疫反应的探索为传染病的预防提供了积极的前景。然而,要提高广义上移植受者或免疫功能低下患者接种疫苗的有效性和安全性,还有很长的路要走。在这些人群中,疫苗接种的利益/风险平衡甚至比一般人群更为明显。因此,在这些人口中持续产生数据非常重要,但可能受到各种人力、技术和财政因素的干扰。在这篇文章中,我们将试图描述一些这些限制免疫应答接种及其探索,特别是在移植受者。
{"title":"Contribution of immunology: immune response to vaccination and limits","authors":"Étienne Brochot","doi":"10.1684/ndt.2023.27","DOIUrl":"https://doi.org/10.1684/ndt.2023.27","url":null,"abstract":"<p><p>Advances over the past 50 years in the field of vaccination and the exploration of the immune response offer positive prospects for the prevention of infectious diseases. However, there is still a long way to go to improve the efficacy and safety of vaccination for transplant recipients or immunocompromised patients in the broad sense. In these populations, the benefit/risk balance of vaccination is even more pronounced in favor than that of the general population. Thus, consistently generating data in these populations is of great importance but can be disrupted by various human, technical and financial factors. In this text, we will attempt to describe some of these limitations for the immune response to vaccination and its exploration, especially in transplant recipients.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 S1","pages":"1-6"},"PeriodicalIF":0.7,"publicationDate":"2023-06-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10065224","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Cardio-renal syndrome: what’s new in 2023? 心肾综合征:2023年有什么新情况?
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.15
Valentin Maisons, Mouad Hamzaoui, Mélanie Hanoy, Théo Pezel, Dominique Guerrot, Dorian Nezam

Cardiac and renal pathologies lead to a high morbidity and mortality rate. The cardio-renal syndrome is characterized by the coexistence of renal and cardiac dysfunction and represents a polymorphic situation that is often complex to understand. This is a common occurrence that constitutes a real public health problem. In this review article, we propose to review the current state of knowledge on this syndrome by focusing on the main physiopathological, epidemiological, clinical and therapeutic aspects.

心脏和肾脏疾病导致高发病率和死亡率。心肾综合征的特点是肾脏和心脏功能障碍并存,是一种复杂的多态情况。这是一种常见现象,构成了真正的公共卫生问题。在这篇综述文章中,我们建议从主要的生理病理、流行病学、临床和治疗方面对该综合征的认识现状进行综述。
{"title":"Cardio-renal syndrome: what’s new in 2023?","authors":"Valentin Maisons,&nbsp;Mouad Hamzaoui,&nbsp;Mélanie Hanoy,&nbsp;Théo Pezel,&nbsp;Dominique Guerrot,&nbsp;Dorian Nezam","doi":"10.1684/ndt.2023.15","DOIUrl":"https://doi.org/10.1684/ndt.2023.15","url":null,"abstract":"<p><p>Cardiac and renal pathologies lead to a high morbidity and mortality rate. The cardio-renal syndrome is characterized by the coexistence of renal and cardiac dysfunction and represents a polymorphic situation that is often complex to understand. This is a common occurrence that constitutes a real public health problem. In this review article, we propose to review the current state of knowledge on this syndrome by focusing on the main physiopathological, epidemiological, clinical and therapeutic aspects.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"121-138"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9926924","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Bee venom: an unusual cause of acute kidney injury 蜂毒:急性肾损伤的不寻常原因
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.19
Aboubacar Sidiki Fofana, Magara Samaké, Seydou Sy, Sah Dit Baba Coulibaly, Abdoulaye Cissé, Moctar Coulibaly, Modi Sidibé, Bakary Sayon Keita, Hamadoun Yattara, Saharé Fongoro

Introduction: Bee sting venom is generally well tolerated. However, some rare cases of massive stings can lead to anaphylactic shock and even renal failure. This observation is the illustration of a case of acute kidney injury secondary to bee stings in a 64-year-old black african subject.

Case presentation: A 64-year-old man without a known medical history was referred to the emergency department of the Fousseyni Daou hospital in Kayes (Mali) for disturbed consciousness 4 hours after massive stings from a bee swarm. Renal failure with serum creatinine level at 752,2 µmol/L was documented on day 3 in a context of total anuria. The patient was transferred to a nephrology unit and biology confirmed renal failure associated with intravascular haemolysis and rhabdomyolysis. The kidneys were of normal size and well differentiated. The diagnosis of severe acute kidney injury due to massive envenomation induced by bee venom was evoked. The evolution was favourable, with normalization of renal function at D26 after 5 sessions of haemodialysis in parallel with transfusions of packed red blood cells.

Conclusion: A massive bee attack should be considered a medical emergency because of the organic damage it can inflict. The renal prognosis depends on the number of stings, and especially on the delay and the quality of the treatment. Early initiation of dialysis treatment reduces mortality.

导读:蜂螫毒液一般耐受良好。然而,在一些罕见的情况下,大量的蜇伤会导致过敏性休克,甚至肾功能衰竭。这一观察是一个病例的急性肾损伤继发于蜜蜂蜇伤在一个64岁的非洲黑人受试者说明。病例介绍:一名没有已知病史的64岁男子在被蜂群大量蜇伤4小时后,因意识紊乱被转介到Kayes(马里)Fousseyni Daou医院急诊科。在全无尿的情况下,第3天记录了肾功能衰竭,血清肌酐水平为752,2µmol/L。患者被转移到肾病科,生物学证实肾功能衰竭与血管内溶血和横纹肌溶解有关。肾脏大小正常,分化良好。唤起对蜂毒大量中毒致严重急性肾损伤的诊断。演进是有利的,在5次血液透析并输注填充红细胞后,D26时肾功能恢复正常。结论:大规模的蜜蜂袭击应被视为医疗紧急情况,因为它可以造成有机损伤。肾脏的预后取决于蜇伤的次数,尤其是治疗的延迟和质量。早期开始透析治疗可降低死亡率。
{"title":"Bee venom: an unusual cause of acute kidney injury","authors":"Aboubacar Sidiki Fofana,&nbsp;Magara Samaké,&nbsp;Seydou Sy,&nbsp;Sah Dit Baba Coulibaly,&nbsp;Abdoulaye Cissé,&nbsp;Moctar Coulibaly,&nbsp;Modi Sidibé,&nbsp;Bakary Sayon Keita,&nbsp;Hamadoun Yattara,&nbsp;Saharé Fongoro","doi":"10.1684/ndt.2023.19","DOIUrl":"https://doi.org/10.1684/ndt.2023.19","url":null,"abstract":"<p><strong>Introduction: </strong>Bee sting venom is generally well tolerated. However, some rare cases of massive stings can lead to anaphylactic shock and even renal failure. This observation is the illustration of a case of acute kidney injury secondary to bee stings in a 64-year-old black african subject.</p><p><strong>Case presentation: </strong>A 64-year-old man without a known medical history was referred to the emergency department of the Fousseyni Daou hospital in Kayes (Mali) for disturbed consciousness 4 hours after massive stings from a bee swarm. Renal failure with serum creatinine level at 752,2 µmol/L was documented on day 3 in a context of total anuria. The patient was transferred to a nephrology unit and biology confirmed renal failure associated with intravascular haemolysis and rhabdomyolysis. The kidneys were of normal size and well differentiated. The diagnosis of severe acute kidney injury due to massive envenomation induced by bee venom was evoked. The evolution was favourable, with normalization of renal function at D26 after 5 sessions of haemodialysis in parallel with transfusions of packed red blood cells.</p><p><strong>Conclusion: </strong>A massive bee attack should be considered a medical emergency because of the organic damage it can inflict. The renal prognosis depends on the number of stings, and especially on the delay and the quality of the treatment. Early initiation of dialysis treatment reduces mortality.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"139-144"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9624841","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Potentially inappropriate medications and anticholinergic and sedative burden in older community-dwelling patients with advanced chronic kidney disease 老年社区居住晚期慢性肾病患者的潜在不适当药物和抗胆碱能及镇静负担
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.6
Maryline Jaffuel, Frederic Gervais, Julien Vernaudon, Marie-Anne Cerfon, Pierre Krolak-Salmon, Christelle Mouchoux, Teddy Novais

Objective: Regarding older patients, multiple chronic conditions lead to the intake of multiple medications, involving a higher risk of adverse drug events. In older patients with advanced chronic kidney disease, the medication exposure was poorly explored. The aim of this study was to describe the use of potentially inappropriate medications and medications with anticholinergic and sedative properties in older community-dwelling patients with advanced chronic kidney disease.

Methods: An observational study was conducted in a geriatric day-care unit. All patients aged over 65 years with advanced chronic kidney disease, defined by estimated glomerular filtration rate < 20 mL/min/1.73 m2 or estimated glomerular filtration rate > 20 mL/min/1.73 m2 with rapid progression, and referred by nephrologist for pretransplant comprehensive geriatric assessment, were included in the study. Potentially inappropriate medications were identified using the EU(7)-PIM list, and he anticholinergic and sedative drug exposure was measured using the Drug Burden Index.

Results: Overall, 139 patients were included in the study (mean age 74.4 ± 3.3 years, 32.4% females, 61.9% on dialysis). Potentially inappropriate medications were used by 74.1% (103/139) of patients and were mainly represented by proton pump inhibitors, alpha-1-blockers and central antihypertensive drugs. Regarding anticholinergic and / or sedative medications, 79.9% (111/139) of older patients were exposed.

Conclusion: In older community-dwelling patients with advanced chronic kidney disease, the prevalence of potentially inappropriate medication exposure and anticholinergic and sedative exposure was high. Interventions focusing on deprescription of these inappropriate medications should be conducted in this specific population.

目的:老年患者多重慢性疾病导致服用多种药物,发生药物不良事件的风险较高。在老年晚期慢性肾脏疾病患者中,药物暴露的研究很少。本研究的目的是描述老年社区居住的晚期慢性肾病患者使用可能不适当的药物和具有抗胆碱能和镇静特性的药物。方法:在老年日托病房进行观察性研究。所有年龄在65岁以上、肾小球滤过率< 20ml /min/1.73 m2或肾小球滤过率> 20ml /min/1.73 m2且进展迅速并经肾科医生转诊进行移植前老年综合评估的晚期慢性肾病患者纳入研究。使用EU(7)-PIM清单确定可能不适当的药物,使用药物负担指数测量抗胆碱能和镇静药物暴露。结果:共纳入139例患者(平均年龄74.4±3.3岁,女性32.4%,透析患者61.9%)。74.1%(103/139)的患者使用了可能不适当的药物,主要为质子泵抑制剂、α -1受体阻滞剂和中枢性降压药。关于抗胆碱能和/或镇静药物,79.9%(111/139)的老年患者暴露。结论:在老年社区居住的晚期慢性肾病患者中,潜在不适当的药物暴露和抗胆碱能和镇静暴露的患病率很高。应在这一特定人群中进行干预,重点是取消这些不适当药物的处方。
{"title":"Potentially inappropriate medications and anticholinergic and sedative burden in older community-dwelling patients with advanced chronic kidney disease","authors":"Maryline Jaffuel,&nbsp;Frederic Gervais,&nbsp;Julien Vernaudon,&nbsp;Marie-Anne Cerfon,&nbsp;Pierre Krolak-Salmon,&nbsp;Christelle Mouchoux,&nbsp;Teddy Novais","doi":"10.1684/ndt.2023.6","DOIUrl":"https://doi.org/10.1684/ndt.2023.6","url":null,"abstract":"<p><strong>Objective: </strong>Regarding older patients, multiple chronic conditions lead to the intake of multiple medications, involving a higher risk of adverse drug events. In older patients with advanced chronic kidney disease, the medication exposure was poorly explored. The aim of this study was to describe the use of potentially inappropriate medications and medications with anticholinergic and sedative properties in older community-dwelling patients with advanced chronic kidney disease.</p><p><strong>Methods: </strong>An observational study was conducted in a geriatric day-care unit. All patients aged over 65 years with advanced chronic kidney disease, defined by estimated glomerular filtration rate < 20 mL/min/1.73 m2 or estimated glomerular filtration rate > 20 mL/min/1.73 m2 with rapid progression, and referred by nephrologist for pretransplant comprehensive geriatric assessment, were included in the study. Potentially inappropriate medications were identified using the EU(7)-PIM list, and he anticholinergic and sedative drug exposure was measured using the Drug Burden Index.</p><p><strong>Results: </strong>Overall, 139 patients were included in the study (mean age 74.4 ± 3.3 years, 32.4% females, 61.9% on dialysis). Potentially inappropriate medications were used by 74.1% (103/139) of patients and were mainly represented by proton pump inhibitors, alpha-1-blockers and central antihypertensive drugs. Regarding anticholinergic and / or sedative medications, 79.9% (111/139) of older patients were exposed.</p><p><strong>Conclusion: </strong>In older community-dwelling patients with advanced chronic kidney disease, the prevalence of potentially inappropriate medication exposure and anticholinergic and sedative exposure was high. Interventions focusing on deprescription of these inappropriate medications should be conducted in this specific population.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"89-98"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9716953","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Kidney biopsy in subsaharan Africa 撒哈拉以南非洲的肾脏活检
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.9
K J N'Dah, W M Tia, D A Lagou, M C Guei, A D Abouna, I Touré, K H Oka, Aar Kobenan, S Diopo, S Delma, I Cherif, E Amékoudi, B S Ouattara, K H Yao, N C Ackoundou, K L Adonis, G V Yao, D A Gnionsahié, Mijm Diomandé

Materials and methods: We carried out a retrospective and descriptive study on biopsies examined between January 2015 and December 2019, in the pathological departments of University Teaching Hospital of Bouaké and Cocody-Abidjan. The KB came from four countries (Côte d'Ivoire, Togo, Guinea-Conakry and Burkina Faso). Optical microscopy and/or direct immunofluorescence techniques were used. All biopsy samples including epidemiological, clinical and pathological data and an optical microscopy and/or direct immunofluorescence study were included. The parameters studied were indications for KB, epidemiological profile, clinic, proteinuria and pathological aspects.

Results: Over the study period, we collected 179 KB, i.e. 35.8 KB/year. The mean age of the patients was 32.9 ±13.8 years (range 11-70 years). The sex ratio (M/F) was 1.03. Pure nephrotic syndrome was the main indication (64.2 %, n = 115) for KB, followed by impure nephrotic syndrome (11.7 %, n = 21), acute renal failure (ARF) (7.8 %, n = 14) and rapidly progressive glomerulonephritis (RPGN) (7.8 %, n = 14). Glomerulonephritis (GN) occurred in 86 % (n = 158), vascular nephropathy in 11.7 % (n = 21) and tubulointerstitial nephritis in 2.2 % (n = 4). The nephropathies were preferentially focal segmental glomerulosclerosis (34.6 %, n = 62), nephroangiosclerosis (10.6 %, n = 19), membranous GN (10 %, n = 18), post-infectious GN (8.9 %, n = 16) and lupus GN (7.3 %, n = 13).

Conclusion: The KB is an essential step in the diagnosis of nephropathies. Focal segmental glomerulosclerosis is frequent in our study. The establishment of a Kidney registry would allow better knowledge of renal pathologies in sub-Saharan Africa.

材料和方法:我们对2015年1月至2019年12月期间在布阿克瓦伊和科科迪-阿比让大学教学医院病理部门检查的活检进行了回顾性和描述性研究。KB来自四个国家(Côte科特迪瓦、多哥、几内亚-科纳克里和布基纳法索)。使用光学显微镜和/或直接免疫荧光技术。所有活检样本包括流行病学、临床和病理资料以及光学显微镜和/或直接免疫荧光研究。研究的参数包括KB的适应症、流行病学、临床、蛋白尿和病理方面。结果:在研究期间,我们收集了179 KB,即35.8 KB/年。患者平均年龄32.9±13.8岁(11 ~ 70岁)。性别比(M/F)为1.03。KB的主要适应症为纯肾病综合征(64.2%,n = 115),其次为不纯肾病综合征(11.7%,n = 21)、急性肾功能衰竭(ARF) (7.8%, n = 14)和快速进展性肾小球肾炎(RPGN) (7.8%, n = 14)。肾小球肾炎(GN)发生率为86% (n = 158),血管性肾病发生率为11.7% (n = 21),肾小管间质性肾炎发生率为2.2% (n = 4),其中以局灶节段性肾小球硬化(34.6%,n = 62)、肾血管硬化(10.6%,n = 19)、膜性肾小球硬化(10%,n = 18)、感染后肾小球肾病(8.9%,n = 16)和狼疮性肾炎(7.3%,n = 13)居多。结论:KB是诊断肾病的重要步骤。局灶节段性肾小球硬化在我们的研究中很常见。肾脏登记的建立将使人们更好地了解撒哈拉以南非洲的肾脏病理。
{"title":"Kidney biopsy in subsaharan Africa","authors":"K J N'Dah,&nbsp;W M Tia,&nbsp;D A Lagou,&nbsp;M C Guei,&nbsp;A D Abouna,&nbsp;I Touré,&nbsp;K H Oka,&nbsp;Aar Kobenan,&nbsp;S Diopo,&nbsp;S Delma,&nbsp;I Cherif,&nbsp;E Amékoudi,&nbsp;B S Ouattara,&nbsp;K H Yao,&nbsp;N C Ackoundou,&nbsp;K L Adonis,&nbsp;G V Yao,&nbsp;D A Gnionsahié,&nbsp;Mijm Diomandé","doi":"10.1684/ndt.2023.9","DOIUrl":"https://doi.org/10.1684/ndt.2023.9","url":null,"abstract":"<p><strong>Materials and methods: </strong>We carried out a retrospective and descriptive study on biopsies examined between January 2015 and December 2019, in the pathological departments of University Teaching Hospital of Bouaké and Cocody-Abidjan. The KB came from four countries (Côte d'Ivoire, Togo, Guinea-Conakry and Burkina Faso). Optical microscopy and/or direct immunofluorescence techniques were used. All biopsy samples including epidemiological, clinical and pathological data and an optical microscopy and/or direct immunofluorescence study were included. The parameters studied were indications for KB, epidemiological profile, clinic, proteinuria and pathological aspects.</p><p><strong>Results: </strong>Over the study period, we collected 179 KB, i.e. 35.8 KB/year. The mean age of the patients was 32.9 ±13.8 years (range 11-70 years). The sex ratio (M/F) was 1.03. Pure nephrotic syndrome was the main indication (64.2 %, n = 115) for KB, followed by impure nephrotic syndrome (11.7 %, n = 21), acute renal failure (ARF) (7.8 %, n = 14) and rapidly progressive glomerulonephritis (RPGN) (7.8 %, n = 14). Glomerulonephritis (GN) occurred in 86 % (n = 158), vascular nephropathy in 11.7 % (n = 21) and tubulointerstitial nephritis in 2.2 % (n = 4). The nephropathies were preferentially focal segmental glomerulosclerosis (34.6 %, n = 62), nephroangiosclerosis (10.6 %, n = 19), membranous GN (10 %, n = 18), post-infectious GN (8.9 %, n = 16) and lupus GN (7.3 %, n = 13).</p><p><strong>Conclusion: </strong>The KB is an essential step in the diagnosis of nephropathies. Focal segmental glomerulosclerosis is frequent in our study. The establishment of a Kidney registry would allow better knowledge of renal pathologies in sub-Saharan Africa.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"99-108"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9927383","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Living donor, first choice]. [活体捐献者,首选]。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.21
Michel Tsimaratos, François Kerbaul
{"title":"[Living donor, first choice].","authors":"Michel Tsimaratos, François Kerbaul","doi":"10.1684/ndt.2023.21","DOIUrl":"10.1684/ndt.2023.21","url":null,"abstract":"","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"81-82"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9706933","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A call for promoting living kidney donation in France in 2023 呼吁2023年在法国推广活体肾脏捐赠
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.20
Christophe Mariat, François Gaillard, Thomas Fournier, Clémentine Rabate, Émilie Pincon, Justine Bacchetta, Manon Aurelle, Antoine Bouquegneau

Kidney transplantation from living donors is particularly under-developed in France in comparison with the US and most European countries. Among others, the lack of a proactive and evidence-based communication from French health providers is a potential cause that has been overlooked thus far. With this as a backdrop, the SFNDT Commission of transplantation has elaborated a 10 points-call for promoting living kidney transplantation in France in 2023 with the aims at (1) providing the entire nephrology community with a scientific rationale and (2) strenghtening the conviction of health providers, patients, and their relatives regarding the relevance of this modality of kidney transplantation.

与美国和大多数欧洲国家相比,活体肾移植在法国尤其不发达。除其他外,法国卫生服务提供者缺乏主动和基于证据的沟通是迄今为止被忽视的一个潜在原因。在此背景下,SFNDT移植委员会制定了2023年在法国促进活体肾移植的10点呼吁,其目的是:(1)为整个肾脏病学界提供科学依据;(2)加强医疗服务提供者、患者及其亲属对这种肾移植方式相关性的信念。
{"title":"A call for promoting living kidney donation in France in 2023","authors":"Christophe Mariat,&nbsp;François Gaillard,&nbsp;Thomas Fournier,&nbsp;Clémentine Rabate,&nbsp;Émilie Pincon,&nbsp;Justine Bacchetta,&nbsp;Manon Aurelle,&nbsp;Antoine Bouquegneau","doi":"10.1684/ndt.2023.20","DOIUrl":"https://doi.org/10.1684/ndt.2023.20","url":null,"abstract":"<p><p>Kidney transplantation from living donors is particularly under-developed in France in comparison with the US and most European countries. Among others, the lack of a proactive and evidence-based communication from French health providers is a potential cause that has been overlooked thus far. With this as a backdrop, the SFNDT Commission of transplantation has elaborated a 10 points-call for promoting living kidney transplantation in France in 2023 with the aims at (1) providing the entire nephrology community with a scientific rationale and (2) strenghtening the conviction of health providers, patients, and their relatives regarding the relevance of this modality of kidney transplantation.</p>","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"83-88"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9409034","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
[Dialysis and quality of life: results of a national survey of patients on dialysis or with experience of dialysis]. [透析与生活质量:对透析患者或有透析经历的患者进行的全国调查的结果]。
IF 0.7 4区 医学 Q3 Medicine Pub Date : 2023-04-26 DOI: 10.1684/ndt.2023.18
Brigitte Thevenin-Lemoine, Didier Borniche, Aurélie Untas, François Vrtovsnik, Luc Frimat, Cécile Couchoud, Cécile Vandevivère
{"title":"[Dialysis and quality of life: results of a national survey of patients on dialysis or with experience of dialysis].","authors":"Brigitte Thevenin-Lemoine, Didier Borniche, Aurélie Untas, François Vrtovsnik, Luc Frimat, Cécile Couchoud, Cécile Vandevivère","doi":"10.1684/ndt.2023.18","DOIUrl":"10.1684/ndt.2023.18","url":null,"abstract":"","PeriodicalId":51140,"journal":{"name":"Nephrologie & Therapeutique","volume":"19 2","pages":"145-151"},"PeriodicalIF":0.7,"publicationDate":"2023-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9624838","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Nephrologie & Therapeutique
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1